the efficiency of the prophylactic treatments given on the basis of the two criteria was also compared in a study of 129 injured patients who were divided in two groups : group 1 ( 50 patients ) received 250 iu of human tetanus immunoglobulin ( hti ) regardless of their tetanus immunity , and group ii ( 79 patients ) received appropriate or no treatment depending on the level of anti-tetanus antibodies determined by trbc-ha assay .
C0039614
tetanus
C0305058
anti-tetanus antibodies